Sam M Pearson (S Pearson, Sam Pearson)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Diabetes, obesity & metabolism

Diabetes & vascular disease research

Diabetic medicine : a journal of the British Diabetic Association

Diabetes, metabolic syndrome and obesity : targets and therapy

Leeds Teaching Hospitals NHS Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leeds Teaching Hospitals NHS Trust

United Kingdom

SPR :: Diabetes and endocrinology

Publications

Nawaz Z Safdar, Anwar M Alobaid, Mark Hopkins, Paddy C Dempsey, Sam M Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi A Ajjan, Matthew D Campbell
Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial. Diabetes, obesity & metabolism 26 (6) (2024)
Nawaz Z Safdar, Anwar M Alobaid, Mark Hopkins, Paddy C Dempsey, Sam M Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi A Ajjan, Matthew D Campbell
Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial. Diabetes, obesity & metabolism (2024)
Nawaz Z Safdar, Anwar M Alobaid, Mark Hopkins, Paddy C Dempsey, Sam M Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi A Ajjan, Matthew D Campbell
Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial. Diabetes, obesity & metabolism 26 (6) (2024)
Matthew D Campbell, Anwar M Alobaid, Mark Hopkins, Paddy C Dempsey, Sam M Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi A Ajjan
Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT-LESS randomised controlled trial. Diabetes, obesity & metabolism (2023)
Sam M Pearson, Noppadol Kietsiriroje, Beverley Whittam, Rebecca J Birch, Matthew D Campbell, Ramzi A Ajjan
Risk factors associated with mortality in individuals with type 2 diabetes following an episode of severe hypoglycaemia. Results from a randomised controlled trial. Diabetes & vascular disease research 19 (1) (2022)
Matthew D Campbell, Daniel J West, Lauren L O'Mahoney, Sam M Pearson, Noppadol Kietsiriroje, Mel Holmes, Ramzi A Ajjan
The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis. Journal of diabetes and metabolic disorders 21 (1) (2022)
Noppadol Kietsiriroje, Sam M Pearson, Lauren L O'Mahoney, Daniel J West, Robert As Ariëns, Ramzi A Ajjan, Matthew D Campbell
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diabetes & vascular disease research 19 (3) (2022)
Rebecca Helliwell, Harriet Warnes, Noppadol Kietsiriroje, Matthew Campbell, Rebecca Birch, Sam M Pearson, Ramzi A Ajjan
Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin. Diabetic medicine : a journal of the British Diabetic Association 38 (5) (2021)
Lauren L O'Mahoney, Noppadol Kietsiriroje, Sam M Pearson, Daniel J West, M Holmes, Ramzi A Ajjan, Matthew D Campbell
Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis. Journal of endocrinological investigation 44 (11) (2021)
Sam M Pearson, Noppadol Kietsiriroje, Ramzi A Ajjan
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date. Diabetes, metabolic syndrome and obesity : targets and therapy 12 (2019)

Sam M Pearson (S Pearson, Sam Pearson)

Publication Activity (10 Years)

Top Topics

Top Venues